Max Healthcare Institute Share Price
993.80-1.10 (-0.11%)
-14.48% past 1 Year
Max Healthcare Institute offers healthcare services through its various facilities in Delhi and the National Capital Region, and facilities in Mohali and Bathinda. It provides services in the areas of
Corporate filings & documents
Announcements
Allotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
3 hours agoInfusion of funds in Kalinga Hospital Ltd.
21 hours agoInfusion of funds in Kalinga Hospital Ltd.
21 hours agoPress Release - Honble Union Home Minister and Cooperation Minister Shri Amit Shah Inaugurates New 400 Beds Tower at Max Smart Super Speciality Hospital Saket
22 hours agoPress Release - Honble Union Home Minister and Cooperation Minister Shri Amit Shah Inaugurates New 400 Beds Tower at Max Smart Super Speciality Hospital Saket
22 hours agoDisclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 week agoDisclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 week agoTranscript of Earnings Call held on August 14 2026
2 weeks agoTranscript of Earnings Call held on August 14 2026
2 weeks agoDisclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 weeks agoDisclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 weeks agoPresentation for Investor Conference
2 weeks agoPresentation for Investor Conference
2 weeks agoNewspaper Publication pertaining to Financial Results for the quarter ended June 30 2026
2 weeks agoNewspaper Publication pertaining to Financial Results for the quarter ended June 30 2026
2 weeks agoAudio Recording of Earnings Call held on August 14 2026
2 weeks agoAudio Recording of Earnings Call held on August 14 2026
2 weeks agoDisclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 weeks agoDisclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 weeks agoChange in Senior Management Personnel
3 weeks agoChange in Senior Management Personnel
3 weeks agoPresentation on earnings updates for the quarter ended June 30 2026
3 weeks agoPresentation on earnings updates for the quarter ended June 30 2026
3 weeks agoPress Release - Max Healthcare Q1 revenue rises to Rs. 2 982 Cr registering growth of 16% YoY; Network Operating EBITDA rises to Rs. 704 Cr 15% YoY; Q1 PAT was Rs. 357 Cr
3 weeks agoPress Release - Max Healthcare Q1 revenue rises to Rs. 2 982 Cr registering growth of 16% YoY; Network Operating EBITDA rises to Rs. 704 Cr 15% YoY; Q1 PAT was Rs. 357 Cr
3 weeks agoOutcome of Board Meeting held on August 13 2026
3 weeks agoOutcome of Board Meeting held on August 13 2026
3 weeks agoResults - Financial Results for the quarter ended June 30 2026
3 weeks agoResults - Financial Results for the quarter ended June 30 2026
3 weeks agoAllotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
3 weeks agoAllotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
3 weeks agoGrant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
3 weeks agoGrant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
3 weeks agoSchedule of Investor Conference
3 weeks agoSchedule of Investor Conference
3 weeks agoSchedule of Earnings Call for Investors and Analysts
3 weeks agoSchedule of Earnings Call for Investors and Analysts
3 weeks agoMax Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter ended June 30 2026
3 weeks agoMax Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter ended June 30 2026
3 weeks agoDisclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
3 weeks agoMinutes of 25th Annual General Meeting
4 weeks agoMinutes of 25th Annual General Meeting
4 weeks agoTranscript of 25th Annual General Meeting
4 weeks agoVoting Results and Scrutinizers Report for 25th Annual General Meeting
1 month agoVoting Results and Scrutinizers Report for 25th Annual General Meeting
1 month agoVoting Results and Scrutinizers Report for 25th Annual General Meeting
1 month agoVoting Results and Scrutinizers Report for 25th Annual General Meeting
1 month agoSummary of Proceedings of 25th Annual General Meeting
1 month agoSummary of Proceedings of 25th Annual General Meeting
1 month agoDisclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
1 month agoConcalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Jan 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
May 2021
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-07-03
Dividend
2.0
2025-07-04
Dividend
1.5
2024-08-23
Dividend
1.5
2023-09-08
Dividend
1.0
Company details
Registered office
401, 4th Floor, Man Excellenza S. V. Road Vile Parle (West) Mumbai Maharashtra PIN: 400056 Tel No: 022-26100461 / 62 Fax No: NULL Email: [email protected] / [email protected] Internet: www.maxhealthcare.in
Registrars
Noble Heights, 1st Floor, Plot NH 2C-1 Block LSC, Near Savitri MarketJanakpuriNew Delhi-11005891-4141-0592/93/9491-4141-0591 Noble Heights, 1st Floor, Plot NH 2 C-1 Block LSC, Near Savitri Market Janakpuri PIN: Tel No: 91-4141-0592/93/94 Fax No: 91-4141-0591 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Dhiraj Aroraa, EVP - Company Secretary & Compliance Officer
Abhay Soi, Chairman & Managing Director
Abhay Soi, Chairman & Managing Director
Amrita Gangotra, Non Executive Independent Woman Director
Anil Bhatnagar, Non Executive Director
Narayan K Seshadri, Non Executive Director
Mahendra Gumanmalji Lodha, Non Executive Independent Director
Michael Thomas Neeb, Non Executive Independent Director
Pranav Amin, Non Executive Independent Director
Pranav Mehta, Non Executive Independent Director
Details
BSE 543220
NSE MAXHEALTH
ISIN INE027H01010